Explore more topics
SEC reporting owner

SIMON NICHOLAS J III SEC insider disclosures

Explore SIMON NICHOLAS J III's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-13T06:40:31.983Z

Reporting owner CIK
0001221595
Issuers
13
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 13 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

COTHERIX INC0001138812CTRXNoYes
PONIARD PHARMACEUTICALS, INC.0000755806NERX, PARDNoYes
AFFYMAX INC0001158223AFFYNoNo
Pharmasset Inc0001301081VRUSNoNo
Somaxon Pharmaceuticals, Inc.0001339455SOMXNoNo
HELICOS BIOSCIENCES CORP0001274563HLCSNoNo
BARRIER THERAPEUTICS INC0001173657BTRXNoYes
PHARMATHENE, INC0001326190HAQ, PIPNoNo
ARYx Therapeutics, Inc.0001410064ARYXNoYes
EnteroMedics Inc0001371217ETRMNoNo
Zalicus Inc.0001135906CRXX, ZLCSNoNo
Radius Health, Inc.0001428522RDUSNoNo
KALOBIOS PHARMACEUTICALS INC0001293310KBIONoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.